Related Experiment Videos

Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an

J L Dickinson1, E J Bates, A Ferrante

  • 1Queensland Cancer Fund Experimental Oncology Unit, Queensland Institute of Medical Research, Brisbane, Australia.

Insights

Plasminogen activator inhibitor type 2 (PAI-2) protects cells from tumor necrosis factor alpha (TNF)-induced apoptosis. This protective role of PAI-2 in inflammatory processes is crucial for regulating cell death.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Plasminogen activator inhibitor type 2 (PAI-2) is a serpin produced by macrophages in response to inflammatory stimuli.
  • Tumor necrosis factor alpha (TNF) is a key cytokine involved in inflammatory processes and apoptosis.

Purpose of the Study:

  • To investigate the role of PAI-2 in TNF-induced apoptotic cell death.
  • To determine the mechanism by which PAI-2 affects TNF sensitivity.

Main Methods:

  • HeLa cells were stably transfected with PAI-2 cDNA or antisense PAI-2 cDNA.
  • Cells were treated with TNF, ultraviolet, or ionizing radiation to induce apoptosis.
  • TNF receptor binding and PAI-2's P1-Arg residue were analyzed.

Main Results:

  • PAI-2 expression protected HeLa cells from TNF-induced apoptosis, inversely correlating with sensitivity.
  • Protection was specific to TNF and not observed with radiation-induced apoptosis.
  • The P1-Arg residue of PAI-2 was essential for its protective function.

Conclusions:

  • Intracellular PAI-2 plays a significant role in regulating cell death during TNF-mediated inflammatory responses.
  • PAI-2 likely inhibits a specific proteinase involved in the TNF apoptotic pathway.
  • PAI-2's function is distinct from its role in regulating urokinase-type plasminogen activator.

Related Concept Videos